The antibiotic monensin causes cell cycle disruption of Toxoplasma gondii mediated through the DNA repair enzyme TgMSH-1

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 2, 2011, Pages 745-755

  Lavine, Mark D ^a   Arrizabalaga, Gustavo ^a  

^a UNIVERSITY OF IDAHO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; METHYLNITROSOUREA; MONENSIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN MUTS; SALINOMYCIN; TGMSH 1; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA GONDII; TRANSCRIPTION REGULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL CYCLE; DNA REPAIR; IONOPHORES; MONENSIN; MUTS HOMOLOG 2 PROTEIN; PROTOZOAN PROTEINS; PYRANS; TOXOPLASMA;

EID: 78751694225     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01092-10     Document Type: Article

References (39)

1. Aebi, S., et al. 1997. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin. Cancer Res. 3:1763-1767.
2. Behnke, M. S., et al. 2010. Coordinated progression through two subtranscriptomes underlies the tachyzoite cycle of Toxoplasma gondii. PLoS One 5:e12354.
3. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. R Stat. Soc. B Stat. Methodol. 57:289-300.
4. Bolstad, B. M., R. A. Irizarry, M. Astrand, and T. P. Speed. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
5. Chen, T., W. Zhang, J. Wang, H. Dong, and M. Wang. 2008. Eimeria tenella: analysis of differentially expressed genes in the monensin- and maduramicin-resistant lines using cDNA array. Exp. Parasitol. 119:264-271.
6. Cleary, M. D., U. Singh, I. J. Blader, J. L. Brewer, and J. C. Boothroyd. 2002. Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression. Eukaryot. Cell 1:329-340.
7. Couzinet, S., J. F. Dubremetz, D. Buzoni-Gatel, G. Jeminet, and G. Prensier. 2000. In vitro activity of the polyether ionophorous antibiotic monensin against the cyst form of Toxoplasma gondii. Parasitology 121(4):359-365.
8. Dalhus, B., J. K. Laerdahl, P. H. Backe, and M. Bjoras. 2009. DNA base repair - recognition and initiation of catalysis. FEMS Microbiol. Rev. 33:1044-1078.
9. Dalmasso, M. C., et al. 2006. Toxoplasma gondii has two lineages of histones 2b (H2B) with different expression profiles. Mol. Biochem. Parasitol. 148:103-107.
10. Dalmasso, M. C., D. O. Onyango, A. Naguleswaran, W. J. Sullivan, Jr., and S. O. Angel. 2009. Toxoplasma H2A variants reveal novel insights into nucleosome composition and functions for this histone family. J. Mol. Biol. 392:33-47.
11. Derouin, F. 2001. Anti-toxoplasmosis drugs. Curr. Opin. Invest. Drugs 2:1368-1374.
12. Downs, J. A., N. F. Lowndes, and S. P. Jackson. 2000. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature 408:1001-1004.
13. Garrison, E. M., and G. Arrizabalaga. 2009. Disruption of a mitochondrial MutS DNA repair enzyme homologue confers drug resistance in the parasite Toxoplasma gondii. Mol. Microbiol. 72:425-441.
14. Gentleman, R. C., et al. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80.
15. Gubbels, M. J., et al. 2008. Forward genetic analysis of the apicomplexan cell division cycle in Toxoplasma gondii. PLoS Pathog. 4:e36.
16. Gubbels, M. J., M. White, and T. Szatanek. 2008. The cell cycle and Toxoplasma gondii cell division: tightly knit or loosely stitched? Int. J. Parasitol. 38:1343-1358.
17. Haberkorn, A. 1996. Chemotherapy of human and animal coccidioses: state and perspectives. Parasitol. Res. 82:193-199.
18. Hickson, I., et al. 2004. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 64:9152-9159.
19. Ihle, N. T., et al. 2004. Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling. Mol. Cancer Ther. 3:763-772.
20. Irizarry, R. A., et al. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:e15.
21. Irizarry, R. A., et al. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
22. Kim, K., and L. M. Weiss. 2004. Toxoplasma gondii: the model apicomplexan. Int. J. Parasitol. 34:423-432.
23. Lawrence, K. 1988. Use of monensin sodium against Toxoplasma. Vet. Rec. 123:323.
24. Li, H. H., X. Cai, G. P. Shouse, L. G. Piluso, and X. Liu. 2007. A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55. EMBO J. 26:402-411.
25. Mahmoudi, N., et al. 2006. Identification of new antimalarial drugs by linear discriminant analysis and topological virtual screening. J. Antimicrob. Chemother. 57:489-497.
26. Marzluff, W. F., E. J. Wagner, and R. J. Duronio. 2008. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet. 9:843-854.
27. Nagamune, K., W. L. Beatty, and L. D. Sibley. 2007. Artemisinin induces calcium-dependent protein secretion in the protozoan parasite Toxoplasma gondii. Eukaryot. Cell 6:2147-2156.
28. O'Brien, V., and R. Brown. 2006. Signalling cell cycle arrest and cell death through the MMR System. Carcinogenesis 27:682-692.
29. Pogorzala, L., S. Mookerjee, and E. A. Sia. 2009. Evidence that msh1p plays multiple roles in mitochondrial base excision repair. Genetics 182:699-709.
30. Radke, J. R., et al. 2001. Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. Mol. Biochem. Parasitol. 115:165-175.
31. Shirley, M. W., A. L. Smith, and D. P. Blake. 2007. Challenges in the successful control of the avian coccidia. Vaccine 25:5540-5547.
32. Singh, M., N. R. Kalla, and S. N. Sanyal. 2006. Effect of monensin on the enzymes of oxidative stress, thiamine pyrophosphatase and DNA integrity in rat testicular cells in vitro. Exp. Toxicol. Pathol. 58:203-208.
33. Smith, C. K., II, and R. B. Galloway. 1983. Influence of monensin on cation influx and glycolysis of Eimeria tenella sporozoites in vitro. J. Parasitol. 69:666-670.
34. Smyth, G. K. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3.
35. Tartakoff, A. M. 1983. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32:1026-1028. (Pubitemid 13033044)
36. Vonlaufen, N., A. Naguleswaran, I. Coppens, and W. J. Sullivan, Jr. 2010. MYST family lysine acetyltransferase facilitates ataxia telangiectasia mutated (ATM) kinase-mediated DNA damage response in Toxoplasma gondii. J. Biol. Chem. 285:11154-11161.
37. Wang, Z., J. Shen, X. Suo, S. Zhao, and X. Cao. 2006. Experimentally induced monensin-resistant Eimeria tenella and membrane fluidity of sporozoites. Vet. Parasitol. 138:186-193.
38. Wang, Z., X. Suo, X. Xia, and J. Shen. 2006. Influence of monensin on cation influx and Na+-K+-ATPase activity of Eimeria tenella sporozoites in vitro. J. Parasitol. 92:1092-1096. (Pubitemid 44863063)
39. Weiss, L. M., and K. Kim. 2000. The development and biology of bradyzoites of Toxoplasma gondii. Front. Biosci. 5:D391-D405.